FO23C5 monoclonal antibody

an anti-CEA IgG1 globulin which recognizes a specific epitope on the protein portion of CEA; it does not react with human granulocytes or with normal colon mucosa; used in detecting CEA expressing tumors

Also Known As:

Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Related Diseases

1.	Colorectal Neoplasms (Colorectal Cancer) 01/01/1991 - "An anti-CEA monoclonal antibody (FO23C5), belonging to the IgG1a class, was used to perform several preclinical and clinical studies on radioimmunoscintigraphy (RIS) in patients with colorectal carcinoma. "
2.	Lung Neoplasms (Lung Cancer) 08/15/1992 - "Imaging lung cancer by scintigraphy with Indium 111-labeled F(ab')2 fragments of the anticarcinoembryonic antigen monoclonal antibody FO23C5."
3.	Bronchogenic Carcinoma 08/15/1992 - "The authors photoscanned with indium 111 (111In)-labeled F(ab')2 fragments of the murine CEA monoclonal antibody FO23C5 63 patients with a newly diagnosed and pathologically documented bronchogenic carcinoma. "
4.	Carcinoma (Carcinomatosis) 10/01/1988 - "Radiolocalisation of an anti-CEA monoclonal antibody (FO23C5) and its fragments in a colon carcinoma xenograft model."

Related Drugs and Biologics

1.	Indium
2.	Antigens